Quadripolar CRT-D On Currently Approved Lead SystemS
Launched by BOSTON SCIENTIFIC CORPORATION · Sep 3, 2014
Trial Information
Current as of May 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject is medically indicated for implantation with a Boston Scientific (BSC) DYNAGEN or INOGEN X4 CRT-D (or any future FDA approved BSC X4 CRT-D) and already implanted with/scheduled to receive a commercially available quadripolar left ventricular lead
- • Subject is willing and capable of providing informed consent and participating in all testing and study visits associated with this investigation at an approved center and at the intervals defined by this protocol
- • Subject is age 18 or above, or of legal age to give informed consent specific to state and national law
- Exclusion Criteria:
- • Subject has a known or suspected sensitivity to dexamethasone acetate (DXA)
- • Subject is enrolled in any other concurrent study, without prior approval from BSC
- • Women of childbearing potential who are or might be pregnant at the time of study enrollment
About Boston Scientific Corporation
Boston Scientific Corporation is a global leader in medical device innovation, dedicated to providing solutions that enhance patient care and improve clinical outcomes. With a strong focus on advancing the treatment of various medical conditions, Boston Scientific develops and manufactures a diverse range of products across multiple specialties, including cardiology, urology, and endoscopy. The company is committed to rigorous clinical research and development, ensuring that its devices meet the highest standards of safety and efficacy. Through collaboration with healthcare professionals and ongoing investment in technology and education, Boston Scientific strives to deliver breakthrough therapies that address unmet medical needs and empower patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Hackensack, New Jersey, United States
Detroit, Michigan, United States
Bryn Mawr, Pennsylvania, United States
Gainesville, Georgia, United States
Munster, Indiana, United States
Atlanta, Georgia, United States
Phoenix, Arizona, United States
Seattle, Washington, United States
Nashville, Tennessee, United States
Jackson, Michigan, United States
Oak Park, Illinois, United States
Augusta, Georgia, United States
Lexington, Kentucky, United States
Manchester, New Hampshire, United States
Gainesville, Florida, United States
Saint Paul, Minnesota, United States
Gilbert, Arizona, United States
Burlington, Vermont, United States
Grand Blanc, Michigan, United States
Bradenton, Florida, United States
Jonesboro, Arkansas, United States
Bakersfield, California, United States
Yuma, Arizona, United States
Saint Petersburg, Florida, United States
Houston, Texas, United States
Scranton, Pennsylvania, United States
Richmond, Virginia, United States
Gainesville, Georgia, United States
Newtown, Pennsylvania, United States
Nashville, Tennessee, United States
Fort Wayne, Indiana, United States
Phoenix, Arizona, United States
Little Rock, Arkansas, United States
Los Angeles, California, United States
Palm Springs, California, United States
Gainesville, Florida, United States
Jacksonville, Florida, United States
Lakeland, Florida, United States
Port Charlotte, Florida, United States
Rockledge, Florida, United States
Sanford, Florida, United States
Sarasota, Florida, United States
Tallahassee, Florida, United States
Atlanta, Georgia, United States
Augusta, Georgia, United States
Winfield, Illinois, United States
Fort Wayne, Indiana, United States
Shreveport, Louisiana, United States
Shreveport, Louisiana, United States
Flint, Michigan, United States
Saint Joseph, Michigan, United States
Las Vegas, Nevada, United States
Atlantic City, New Jersey, United States
Buffalo, New York, United States
Zanesville, Ohio, United States
Jackson, Tennessee, United States
Houston, Texas, United States
Lufkin, Texas, United States
The Woodlands, Texas, United States
Green Bay, Wisconsin, United States
Patients applied
Trial Officials
Christopher R Ellis, MD
Principal Investigator
Vanderbilt University Medical Center, Nashville, TN
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials